FDA Risk Communication Committee Recommends Clarity, Predictability
This article was originally published in The Tan Sheet
FDA's Risk Communication Advisory Committee submitted six broad recommendations Nov. 12 with an emphasis on making product risk announcements more predictable and available more quickly
You may also be interested in...
Findings from an FDA survey of physicians about their use and perceptions of emerging drug risk information could add a new tenor to the debate about the value of communicating early risk signals
Perrigo promotes in pricing, planning
Combe sells most of its OTC brands